Transcripts of the Prostate Cancer-Associated Gene

Olli Metsälä, Gudrun Wahlström, Pekka Taimen, Pirkko-Liisa Kellokumpu-Lehtinen, Johanna Schleutker

Open access · goldAbstract read

In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.7field-weighted citation impact, top 25% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

ANO7 expression in the prostate modulates mitochondrial function and lipid metabolism.Cell communication and signaling : CCS · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Olli MetsäläInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 25020 Turku, Finland.ORCID 0000-0002-6048-2991

Gudrun WahlströmInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 25020 Turku, Finland.

Pekka TaimenInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 25020 Turku, Finland.ORCID 0000-0001-8849-4604

Pirkko-Liisa Kellokumpu-LehtinenFaculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.

Johanna SchleutkerInstitute of Biomedicine, University of Turku, Kiinamyllynkatu 10, 25020 Turku, Finland.ORCID 0000-0002-1863-0305

University of Turku · FITampere University · FI

Funding

Academy of Finland #310105Cancer Foundation Finland sr n/aJane and Aatos Erkko Foundation n/aSigrid Juselius Foundation n/aState Research Funding of Turku and Tampere University Hospitals n/a

6 · The paper itself

Abstract

Prostate cancer affects millions of men globally. The prostate cancer-associated gene

Indexed as

ProstateProstatic NeoplasmsAnoctaminsEpithelial CellsHumansIn Situ Hybridization, FluorescenceMaleRNA, MessengerANO7 protein, humanAnoctaminsRNA, MessengeranoctaminmRNAnuclear retentionprostate cancer

Identifiers

PMID36674564

DOI10.3390/ijms24021052

PMCPMC9865797

OpenAlexW4313572740

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.